Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

This study has been terminated.

(Low accrual due to competing trial.)

Sponsor:

Collaborator:

Information provided by (Responsible Party):

M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:

NCT00080782

First received: April 7, 2004

Last updated: July 27, 2012

Last verified: August 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2005
Primary Completion Date:	April 2004 (Final data collection date for primary outcome measure)